Sid Taubenfeld is a registered pharmacist, who started his career as a clinical pharmacist at Bellevue Hospital in the area of Critical medicine, Clinical trials and Total Parenteral Nutrition. He also did graduate work in Pharmacology at NY Medical College. Following his work at Bellevue, Sid served as a buy-side healthcare equities research analyst /portfolio manager for 19 years at various Wall Street Healthcare funds, including Balyasny Asset Management (BAM), RH Capital, Scopia Capital and PAW Partners. His areas of coverage focused on major and specialty pharmaceutical companies as well as the biotechnology sector. Additionally, Sid has worked as Director of Strategic Initiatives at Celsion Corporation an Oncology biotech company.